GHK-Cu peptide and anti-aging skincare: what TikTok gets wrong

What's this video probably claiming?

Based on the hashtags and creator context, @brandonskincare is likely walking viewers through a topical anti-aging routine that combines prescription-strength actives like tretinoin with peptide-based ingredients, most probably copper peptide GHK-Cu. The framing as "evidence-based" is a signal that the creator is positioning peptides not as trendy add-ons but as scientifically legitimate anti-aging tools alongside retinoids. Expect claims that GHK-Cu boosts collagen synthesis, improves skin density, and works synergistically with tretinoin to accelerate skin renewal. There may also be discussion of growth factor stimulation, wound healing acceleration, and comparisons between topical peptide serums and other actives. The ASMR framing suggests a slow, product-focused walkthrough, which tends to amplify product trust without rigorous sourcing. The "evidence-based" label in the caption sets a high bar, one that deserves actual scrutiny.

What does the science actually show?

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) has a more legitimate research foundation than most TikTok peptide darlings. Pickart and Margolina (2018, Cosmetics) compiled evidence showing GHK-Cu upregulates collagen I, III, and VI synthesis and activates matrix metalloproteinases to clear damaged protein. A small but real 2009 double-blind trial by Leyden et al. (Journal of Cosmetic Dermatology) found statistically significant improvements in fine lines and skin density after 12 weeks of topical application at concentrations around 2-3%. Importantly, these are topical concentration effects, not systemic peptide therapy effects. Penetration depth matters enormously here. Most published in vitro data uses concentrations far higher than what a consumer serum actually delivers to dermis. Tretinoin's anti-aging evidence is considerably more strong, with decades of randomized controlled trial data, including Kligman et al.'s foundational work showing measurable epidermal thickening and collagen induction at 0.025-0.1% concentrations over 24 weeks.

Where does the social media noise diverge from clinical reality?

The main problem is conflation. TikTok creators routinely blur the line between injectable or systemic peptide therapy data and topical cosmetic peptide results. GHK-Cu used in wound-healing and tissue-repair research is frequently delivered at systemic doses in controlled settings, not smeared on in a 1% serum at pH 5.5. When a creator cites a study on copper peptide regeneration, they often fail to mention whether that study was in vitro, in vivo animal, or an actual human RCT. The second issue is the synergy narrative. Combining tretinoin with GHK-Cu sounds logical since tretinoin causes irritation and GHK-Cu has documented anti-inflammatory properties, but there is no published RCT specifically testing this combination for efficacy or safety. Creators also tend to ignore the well-documented instability of copper peptides in formulations containing acidic actives like vitamin C or low-pH exfoliants, which can oxidize and inactivate the complex before it even contacts skin.

What should you actually know?

Topical GHK-Cu is one of the better-supported cosmetic peptides, but the evidence ceiling is lower than anti-aging influencers imply. Real clinical trials are small, often industry-funded, and rarely compare GHK-Cu head-to-head against tretinoin or retinol at matched timepoints. If your goal is measurable collagen induction with genuine long-term data behind it, tretinoin still has the strongest evidence base at the lowest cost. GHK-Cu is a reasonable adjunct for users who cannot tolerate retinoid irritation, but it is not a replacement and should not be framed as equivalent. Formulation stability matters practically: look for products with copper peptide stored away from vitamin C and at a pH of 6-7 for optimal activity. Any creator calling a routine "evidence-based" should be able to name specific studies, name specific concentrations, and acknowledge where the evidence runs thin. If they cannot, the label is marketing, not methodology.